IR
Superintel
Overview
Markets
Watchlist
More
Call (Akba) Akebia Therapeutics JAN 15 27 $1.5 (100 SHS)
Q1 2026 vs Q2 2026
Comparing institutional holders between quarters
Quarters
Q2 2026
Q1 2026
Compare
Detailed
Historical
Funds
Options
Short Interest
13D/13G
Peers
Targeting
Trading Summary
Profile
1
Filed
0
New
0
Closed
0
Increased
0
Decreased
1
Unchanged
0
No Data
Sort by
Q2 2026 shares — high to low
Q2 2026 shares — low to high
Share change — largest gain
Share change — largest cut
% change — largest gain
% change — largest cut
Q2 2026 value — high to low
Value change — largest gain
Value change — largest cut
Institution — A to Z
Filed — newest first
Core Alternative Capital
UNCHANGED
Shares
50
from 50
Change
0
(0%)
Value
$1.6K
(-$1.3K)
Filed 2026-08-14
Institution
Status
Q2 2026 ↓
Q1 2026
Change
% Change
Q1 2026 Value
Q2 2026 Value
Value Change
Filed
Core Alternative Capital
UNCHANGED
50
50
0
0%
$2.8K
$1.6K
-$1.3K
2026-08-14
Showing 1 of 1 institutions